Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
herbal medicine-Jaseng Medical Foundation refers to a specific traditional Korean medicine (TKM) formulation, often identified as Chungpa-jeon or its standardized extract GCSB-5, developed by the Jaseng Medical Foundation. It is primarily used for the treatment of musculoskeletal disorders, specifically cervical disc herniation with radiculopathy. The formulation is a complex mixture of herbal ingredients, including Acanthopanax sessiliflorus, Eucommia ulmoides, Saposhnikovia divaricata, Achyranthes bidentata, Cibotium barometz, and Glycine max. It is administered orally as a water-based decoction or in pill and powder forms. The medicine exerts therapeutic effects through anti-inflammatory action, edema reduction, and the promotion of nerve, muscle, ligament, and bone regeneration. It is typically used as a core component of an integrative Korean medicine treatment plan that includes acupuncture, pharmacopuncture, and Chuna manual therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on herbal medicine-Jaseng Medical Foundation.